PTPI — Petros Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Petros Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	17.1	23.8	9.43	13.3	3.71
Net Total Accounts Receivable
Net Total Receivables	5.15	2.46	2.11	2.23	0.416
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	25.9	30.5	14.7	20.4	7.29
Net Property, Plant And Equipment	0.644	0.525	0.398	0.255	0.137
Net Intangible Assets
Other Long Term Assets
Total Assets	69.9	67.4	32.4	33.8	10.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	41.9	31	7.07	10.8	18
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	52.4	31.8	15.7	21.3	18.1
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	17.5	35.5	16.7	12.5	-7.47
Total Liabilities & Shareholders' Equity	69.9	67.4	32.4	33.8	10.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding